Thursday, September 1, 2016

FDA Approves New Biological Drug for RA

Erelzi is a biosimilar for Enbrel


http://onlinemedicalassistantprogramsedu.com/wp-content/uploads/2016/09/default.jpg
To learn more visit: WebMD Health

http://www.arthritistreatmentcenter.com
Biologics going down in price? Maybe… coming up next
First biosimilar biologic approved in Europe.
Reported in Value-based Rheumatology, an article indicating the European Commission has approved the first biosimilar biologic for the treatment of rheumatoid arthritis. Two versions, Remsima and Inflectra are copies of the popular drug Remicade. Approval of biosimilars may herald the reduction in costs for these costly drugs.
Comment: Let’s hope these work as well as the brand name drugs.

The post FDA Approves New Biological Drug for RA appeared first on Online Medical Assistant Training Programs.

FDA Approves New Biological Drug for RA




from WordPress https://onlinemedicalassistantprogramsedu.wordpress.com/2016/09/01/fda-approves-new-biological-drug-for-ra/

No comments:

Post a Comment